US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 2.880
  • -0.220-7.10%
Trading Dec 12 13:43 ET
309.36MMarket Cap-2.50P/E (TTM)

Tango Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tango Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.370M--
--2024/Q4-- / 8.018M--
--2024/Q311.607M / 8.066M--
--2024/Q219.875M / 7.632M--
--2024/Q16.471M / 7.505M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 7.370M--
--2024/Q4-- / 8.018M--
--2024/Q311.607M / 8.066M--
--2024/Q219.875M / 7.632M--
--2024/Q16.471M / 7.505M--

Unlock Free Earnings Estimates

Tango Therapeutics Earnings Reports

  • Tango Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 07:47 ET

  • Tango Therapeutics | 8-K: Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

    Nov 6 07:27 ET

  • Tango Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 07:16 ET

  • Tango Therapeutics | 8-K: Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

    Aug 7 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data